Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Polycystic Ovary Syndrome 3 Pain, Postoperative 2 Breast Neoplasms 2 Vomiting 1 Vitamin D Deficiency 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Nausea 1 Motor Activity 1 Malnutrition 1 Gastritis, Atrophic 1 Disease 1 Carcinoma, Transitional Cell 1 Breast Neoplasms, Male 1

Interventions

pembrolizumab 91 Gemcitabine 55 Nivolumab 49 Cisplatin 38 atezolizumab 31 Carboplatin 30 avelumab 25 enfortumab vedotin 23 Docetaxel 23 Magnetic Resonance Spectroscopy 18 Ipilimumab 17 Paclitaxel 16 Mitomycin 15 Specimen Handling 14 durvalumab 11 toripalimab 10 sacituzumab govitecan 10 Pemetrexed 10 cabozantinib 9 Taxes 8 vinflunine 7 Cyclophosphamide 7 tislelizumab 6 Injections 6 Bevacizumab 6 pemigatinib 5 fludarabine 5 disitamab vedotin 5 Standard of Care 5 Radiosurgery 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Carcinoma, Transitional Cell × Vitamins × Clear all

NCT01490437 2014-09-25

PECULIAR

Asan Medical Center

Phase 2 Completed

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡